Adjunctive Therapy of Exenatide or Sitagliptin to Insulin Glargine in Type 2 Diabetes

NCT00971659 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

48

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 2 Diabetes

Interventions

DRUG: insulin glargine + exenatide + preexisting metformin
DRUG: insulin glargine + sitagliptin + preexisting metformin
DRUG: insulin glargine + preexisting metformin

Sponsor

Profil Institut für Stoffwechselforschung GmbH

Collaborators

[object Object]